Skip to main content
. Author manuscript; available in PMC: 2007 Aug 13.
Published in final edited form as: J Clin Endocrinol Metab. 2005 Aug 23;90(11):5921–5927. doi: 10.1210/jc.2004-2253

TABLE 2.

Properties of ESR2 SNPs tested in this study

SNP   Allelea    Functionb    Minor allele frequencyc    HWE P valuec    Missing rate (%)   Validation method
rs1256112   A→G   Promoter   0.44   0.81   5.0   BsmAI
rs3020444   T→C   Promoter   0.32   0.67   4.0   HphI
rs1887994   G→T   5′‐Untranslated region   0.09   0.43   4.0   ApoI
rs1952586   A→G   5′‐Untranslated region   0.11   0.28   7.8   TfiI
rs1256030   C→T   Intron 1   0.46   0.33   4.5   AluI
rs1269056   G→A   Intron 2   0.43   0.52   4.1   Sequencing
rs1256044   T→C   Intron 3   0.43   0.43   4.6   MspI
rs1256049   G→A   Exon 5   0.03   0.20   3.9   RsaI
rs1952585   T→C   Intron 6   0.07   0.99   3.9   DdeI
rs4986938   G→A   3′ Flanking region   0.37   0.88   3.4   AluI
rs1152588d   G→C   3′ Flanking region   0.45   0.43   5.3   BsrI
a

Given in the orientation of the ESR2 gene (i.e. minus/reverse strand).

b

Based on the ESR2 reference sequence (see Fig. 1).

c

Minor allele frequency and Hardy‐Weinberg equilibrium (HWE) P value were calculated from 753 unrelated samples.

d

Located in the spectrin repeat containing nuclear envelope 2 (SYNE2) gene.